<unk>  is a test that tries to determine the risk of some who is seriously sick developing acute kidney injury. Whether or not the test improves outcomes, however, is unclear as of 2016.<unk>  tests for the presence of insulin-like growth-factor binding protein 7 (IGFBP7) and tissue inhibitor of metalloproteinases (TIMP-2) in the urine, which are associated with acute kidney injury. The laboratory test was developed by Astute Medical, in San Diego, California.
NephroCheck
Gravindex
Barostat
MNsure
ReFLEX
ALECSAT
MDCalc
COMLEX-USA